Evogene Ltd. (EVGN)
1.10
+0.02
(+1.85%)
USD |
NASDAQ |
Feb 09, 11:48
Evogene EPS Diluted (Quarterly) : 0.4444 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MediWound Ltd. | -0.2406 |
| Nano-X Imaging Ltd. | -0.2127 |
| Compugen Ltd. | -0.0746 |
| Pluri, Inc. | -0.6503 |
| BioLineRx Ltd. | -0.223 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.729M |
| Revenue (Quarterly) | 0.312M |
| Total Expenses (Quarterly) | 4.364M |
| Enterprise Value | 12.09M |
| Gross Profit Margin (Quarterly) | -40.38% |
| Profit Margin (Quarterly) | -874.7% |
| Earnings Yield | -44.62% |
| Normalized Earnings Yield | -44.62 |